Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk

Dow Jones

Jan 19

2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. "We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services," says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

January 18, 2026 18:40 ET (23:40 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2604970907"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2604970907\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2604970907?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-19 07:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604970907","market":"nz","top_or_hot":-1,"title":"Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 18, 2026 18:40 ET (23:40 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-19 07:40</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 18, 2026 18:40 ET (23:40 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"COH.AU","symbol_name":"COCHLEAR LTD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2604970907","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604970907","pubTimestamp":1768779600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"COH.AU":"COCHLEAR LTD","BK7007":"医疗保健设备"},"translate_title":"尽管上半年盈利可能低于预期，科利耳仍获得新的牛市——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COH.AU":0.9},"content_text":"2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 18, 2026 18:40 ET (23:40 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}